A NEW ENTITY OF T LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) RESPONDING TO TYROSINE KINASE INHIBITOR (IMATINIB MESYLATE): COMPLETE CHARACTERIZATION OF A PEDIATRIC CASE WITH RESISTANT DISEASE

被引:0
|
作者
Lo Nigro, Luca [1 ]
Barresi, Vincenza [2 ]
Mirabile, Elena [1 ]
Musso, Nicolo [2 ]
Capizzi, Carmela [2 ]
Corbacioglu, Selim [3 ]
Poli, Amelia [1 ]
Tumino, Manuela [4 ]
Di Cataldo, Andrea [5 ]
Condorelli, Daniele [2 ]
机构
[1] Azienda Policlin Univ Catania, Ctr Pediat Hematol, Catania, Italy
[2] Univ Catania, Scuola Super, Catania, Italy
[3] Univ Ulm, Mol Biol Lab, Ulm, Germany
[4] Univ Catania, Dept Pediat, Catania, Italy
[5] Univ Catania, Ctr Pediat Hematol Oncol, Catania, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:855 / 855
页数:1
相关论文
共 50 条
  • [21] Distribution and Clinical Features of NOTCH1 Signaling Activating Alterations in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Kimura, Shunsuke
    Seki, Masafumi
    Yoshida, Kenichi
    Ueno, Hiroo
    Nannya, Yasuhito
    Ohki, Kentaro
    Kato, Motohiro
    Koh, Katsuyoshi
    Kobayashi, Ryoji
    Deguchi, Takao
    Hashii, Yoshiko
    Imamura, Toshihiko
    Sato, Atsushi
    Kiyokawa, Nobutaka
    Manabe, Atsushi
    Horibe, Keizo
    Ohara, Akira
    Sanada, Masashi
    Hiwatari, Mitsuteru
    Kobayashi, Masao
    Oka, Akira
    Miyano, Satoru
    Ogawa, Seishi
    Takita, Junko
    BLOOD, 2018, 132
  • [22] Lack of Protein Kinase C Alpha Is Associated with Poor Prognosis in Pediatric T-Lineage Acute Lymphoblastic Leukemia
    Milani, Gloria
    Accordi, Benedetta
    Giordan, Marco
    Bresolin, Silvia
    Galla, Luisa
    Sciro, Maimela
    Vendramini, Elena
    Cazzaniga, Giovanni
    Kronnie, Geertruy
    Basso, Giuseppe
    BLOOD, 2011, 118 (21) : 338 - 338
  • [23] Characterization and DNA methyltransferase inhibitor treatment of primary murine T/NK acute lymphoblastic leukemia (ALL).
    VanDeusen, JB
    Yu, L
    Blaser, BW
    Mao, C
    Guimond, M
    Le Beau, MM
    Klisovic, MI
    Marcucci, G
    Plass, C
    Caligiuri, MA
    BLOOD, 2003, 102 (11) : 627A - 627A
  • [24] Regulation of c-kit Oncogene by Ikaros and Casein Kinase II (CK2) in T Cell Acute Lymphoblastic Leukemia (T-ALL)
    Gowda, Chandrika
    Kapadia, Malika
    Song, Chunhua
    Xiang, Meixian
    Ding, Yali
    Payne, Kimberly
    Dovat, Sinisa
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S1 - S2
  • [25] Analysis of the Distribution and Clinical Features of Alterations Activating NOTCH1 Signaling in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Kimura, S.
    Seki, M.
    Yoshida, K.
    Ueno, H.
    Ohki, K.
    Koh, K.
    Kobayashi, R.
    Deguchi, T.
    Hashii, Y.
    Imamura, T.
    Sato, A.
    Kiyokawa, N.
    Manabe, A.
    Horibe, K.
    Ohara, A.
    Sanada, M.
    Kobayashi, M.
    Miyano, S.
    Ogawa, S.
    Takita, J.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S128 - S128
  • [26] Analysis of the Distribution and Clinical Features of Alterations Activating NOTCH1 Signaling in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Kimura, S.
    Seki, M.
    Yoshida, K.
    Ueno, H.
    Ohki, K.
    Koh, K.
    Kobayashi, R.
    Deguchi, T.
    Hashii, Y.
    Imamura, T.
    Sato, A.
    Kiyokawa, N.
    Manabe, A.
    Horibe, K.
    Ohara, A.
    Sanada, M.
    Kobayashi, M.
    Miyano, S.
    Ogawa, S.
    Takita, J.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S79 - S80
  • [27] Outcome of Adults with Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) Included in Minimal Residual Disease (MRD)-Oriented Trials
    Ribera, Josep-Maria
    Chapchap, Eduardo Cerello
    Morgades, Mireia
    Genesca, Eulalia
    Gil, Cristina
    Garcia-Cadenas, Irene
    Barba, Pere
    Gonzalez-Campos, Jose
    Torrent, Anna
    Del Castillo, Teresa Bernal
    De Llano, Maria Paz Queipo
    Amigo, Maria-Luz
    Tormo, Mar
    Coll, Rosa
    Vall-Llovera, Ferran
    Ribera, Jordi
    Sanchez, Maria Jose
    Soria, Beatriz
    Cladera, Antonia
    Artola, Maria Teresa
    Garcia-Guinon, Antoni
    Conca, Alberto Gimenez
    Barciela, Lourdes Amador
    Ciudad, Juana
    Orfao, Alberto
    BLOOD, 2020, 136
  • [28] Acute myeloid leukemia (AML) after BMT in a patient with acute T-lymphoblastic leukemia (T-ALL) in CR, with no detectable minimal residual disease by flow-cytometry.
    Benedetti, F
    Krampera, M
    Veneri, D
    Grassi, A
    Micheletti, M
    Maggioni, A
    Vincenzi, C
    Perona, G
    BONE MARROW TRANSPLANTATION, 1999, 23 : S145 - S145
  • [29] DUAL INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) AND mTOR AS A NEW THERAPEUTIC OPTION FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)
    Chiarini, F.
    Grimaldi, C.
    Tazzari, P. L.
    Ricci, F.
    Pagliaro, P.
    Martelli, A. M.
    CYTOMETRY PART A, 2010, 77A (02) : 167 - 167
  • [30] Targeting a Specific Glycosylated Epitope of CD43 with a New Humanized Monoclonal Antibody for the Treatment of Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Botta, Cirino
    Gaipa, Giuseppe
    Cantafio, Maria Eugenia Gallo
    Buracchi, Chiara
    Siciliano, Maria Anna
    Riillo, Caterina
    Grillone, Katia
    Gulino, Alessandro
    Cuce, Maria
    Staropoli, Nicoletta
    Di Rora, Andrea Ghelli Luserna
    Tuccillo, Franca Maria
    Di Martino, Maria Teresa
    Tripodo, Claudio
    Rossi, Marco
    Martinelli, Giovanni
    Biondi, Andrea
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    BLOOD, 2018, 132